Vaccine biotechnology company Ufovax announced it will begin phase I clinical trials of its one-component, self-assembling protein nanoparticle (1c-SApNP) SARS-CoV-2 vaccine.
Clinical-stage biotechnology company Axon Neuroscience plans to start clinical trials of an independently developed, crowdfunded vaccine against COVID-19 called ACvac1.
A new Science article describes the legal and ethical implications of do-it-yourself (DIY) COVID-19 vaccines.
Elicio Therapeutics and the Moffitt Cancer Center have established a collaboration to study Elicio's amphiphile immunotherapies with CD19 chimeric antigen receptor-T (CAR-T) cells.
ImmunoPrecise and Zymeworks have announced that they have formed a research collaboration to develop a multispecific SARS-CoV-2 antibody.
Lykan Bioscience has opened a new, 64,000-sq-ft "smart" manufacturing facility in Hopkinton, MA.
Moderna and Vertex Pharmaceuticals have entered a three-year research collaboration for the discovery and development of lipid nanoparticles and messenger RNAs for the delivery of gene editing therapies for the treatment of cystic fibrosis.
Eli Lilly and Amgen will collaborate on global antibody manufacturing to significantly increase the supply capacity of Lilly's potential COVID-19 therapies.
Agilent Technologies has launched a new product offering, the Agilent NovoCyte Penteon, a flow cytometer with five lasers and up to 30 fluorescence channels.
AVM Biotechnology received authorization for an investigational new drug application from the U.S. Food and Drug Administration to evaluate its proprietary drug, AVM0703, in the treatment of acute respiratory distress syndrome mediated by COVID-19 or influenza patients.
Insights
Exclusive content for Science Advisory Board members on trends and outcomes that are influencing the future of scientific research.
Communities
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Rewards
Earn points for contributing to research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Connect
